ARTICLE
25 March 2026

HPE Miami 2026: Where Healthcare Dealmakers See Opportunity

At HPE Miami, the industry’s leading investors and operators came together to share what’s now—and what’s next. Dive into the highlights, from key stats to candid conversations and real-time perspectives...
United States Food, Drugs, Healthcare, Life Sciences
McDermott Will & Schulte’s articles from McDermott Will & Schulte are most popular:
  • within Food, Drugs, Healthcare and Life Sciences topic(s)
  • in United States
  • with readers working within the Automotive industries
McDermott Will & Schulte are most popular:
  • within Food, Drugs, Healthcare, Life Sciences, Cannabis & Hemp and Privacy topic(s)

At HPE Miami, the industry’s leading investors and operators came together to share what’s now—and what’s next. Dive into the highlights, from key stats to candid conversations and real-time perspectives, to see where opportunity is emerging, how dealmakers are navigating market headwinds, and the strategies driving healthcare investing forward.

What will most influence healthcare PE performance in the next 12 months?

1764400a.jpg

1764400b.jpg

What is the biggest challenge facing healthcare transactions in the next 12 months?

1764400c.jpg

What will unlock deal flow in 2026?

1764400d.jpg

1764400e.jpg

Where is deal momentum heading into 2026?

1764400f.jpg

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More